Inhibition of tumor angiogenesis by a natural fragment of a tRNA synthetase

Wakasugi, 1999, Two distinct cytokines released from a human aminoacyl-tRNA synthetase, Science, 284, 147, 10.1126/science.284.5411.147 Nyberg, 2005, Endogenous inhibitors of angiogenesis, Cancer Res., 65, 3967, 10.1158/0008-5472.CAN-04-2427 Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108 Lee, 2004, Aminoacyl-tRNA synthetase complexes: beyond translation, J. Cell Sci., 117, 3725, 10.1242/jcs.01342 Wakasugi, 2002, Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase, J. Biol. Chem., 277, 20124, 10.1074/jbc.C200126200 Otani, 2002, Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis, Nat. Med., 8, 1004, 10.1038/nm744 Fleckner, 1995, Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines, Cytokine, 7, 70, 10.1006/cyto.1995.1009 Turpaev, 1996, Alternative processing of the tryptophanyl-tRNA synthetase mRNA from interferon-treated human cells, Eur. J. Biochem., 240, 732, 10.1111/j.1432-1033.1996.0732h.x Salvucci, 2004, Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-α and IFN-γ, J. Leukoc. Biol., 76, 217, 10.1189/jlb.1203609 Yang, 2004, Relationship of two human tRNA synthetases used in cell signaling, Trends Biochem. Sci., 29, 250, 10.1016/j.tibs.2004.03.002 Kise, 2004, A short peptide insertion crucial for angiostatic activity of human tryptophanyl-tRNA synthetase, Nat. Struct. Mol. Biol., 11, 149, 10.1038/nsmb722 Otani, 2002, A fragment of human TrpRS as a potent antagonist of ocular angiogenesis, Proc. Natl. Acad. Sci. U. S. A., 99, 178, 10.1073/pnas.012601899 Tzima, 2003, Biologically active fragment of a human tRNA synthetase inhibits fluid shear stress-activated responses of endothelial cells, Proc. Natl. Acad. Sci. U. S. A., 100, 14903, 10.1073/pnas.2436330100 Tzima, 2005, VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function, J. Biol. Chem., 280, 2405, 10.1074/jbc.C400431200 Dejana, 2001, Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration, Thromb. Haemost., 86, 308, 10.1055/s-0037-1616228 Carmeliet, 1999, Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis, Cell, 98, 147, 10.1016/S0092-8674(00)81010-7 Corada, 2002, A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability, Blood, 100, 905, 10.1182/blood.V100.3.905 Liao, 2002, Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability, Cancer Res., 62, 2567 Dejana, 2004, Endothelial cell–cell junctions: happy together, Nat. Rev. Mol. Cell Biol., 5, 261, 10.1038/nrm1357 Min, 1996, Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice, Cancer Res., 56, 2428 Liao, 2000, Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis, Cancer Res., 60, 6805 May, 2005, Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature, Blood, 105, 4337, 10.1182/blood-2005-01-0010 Blankesteijn, 2000, B-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction, Am. J. Pathol., 157, 877, 10.1016/S0002-9440(10)64601-9 Lambeng, 2005, Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues, Circ. Res., 96, 384, 10.1161/01.RES.0000156652.99586.9f Bazzoni, 1999, Endothelial adhesion molecules in the development of the vascular tree: the garden of forking paths, Curr. Opin. Cell Biol., 11, 573, 10.1016/S0955-0674(99)00023-X Al-Kurdi, 2004, A soluble VE-cadherin fragment forms 2D arrays of dimers upon binding to a lipid monolayer, J. Mol. Biol., 337, 881, 10.1016/j.jmb.2004.02.021 Corada, 1999, Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo, Proc. Natl. Acad. Sci. U. S. A., 96, 9815, 10.1073/pnas.96.17.9815 Corada, 2001, Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability, Blood, 97, 1679, 10.1182/blood.V97.6.1679